Imported Case of Poliomyelitis, Melbourne, Australia, 2007

Wild poliovirus–associated paralytic poliomyelitis has not been reported in Australia since 1977. We report type 1 wild poliovirus infection in a man who had traveled from Pakistan to Australia in 2007. Poliomyelitis should be considered for patients with acute flaccid paralysis or unexplained fever who have been to poliomyelitis-endemic countries.

except the pain resolved. On July 2, he traveled back to Melbourne.
Starting on July 3, the patient's pain increased and lower limb weakness subsequently returned, accompanied by upper limb tremors. He had neither systemic symptoms nor bladder or bowel dysfunction. He was referred to Boxhill Hospital, Eastern Health, emergency department on July 6. Physical examination found that the patient's legs were tender to palpation and that strength was mildly reduced in the entire left leg and proximal right leg. Lower limb refl exes and sensation, as well as cranial nerve and upper limb function, were within normal limits. Laboratory results of blood tests were within reference ranges.
The next day, MRI was highly suggestive of poliomyelitis. It showed a globular pattern of increased signal on T2-weighted sequences, limited to the anterior horn region throughout the spinal cord, without enhancement with gadolinium ( Figure 1). The Department of Human Services, Victoria, was notifi ed of the clinical diagnosis of poliomyelitis; the patient was admitted to a single room, and contact precautions were instituted. Panenterovirus reverse transcription-PCR (RT-PCR) of feces, serum, and throat swab produced negative results, but the samples were forwarded to the NPRL for cell culture 2 days later (Table). Cerebrospinal fl uid contained 1 × 10 6 polymorphonuclear cells, 8 × 10 6 lymphocytes, 24 × 10 6 erythrocytes, a protein concentration of 1.9 g/L, and glucose levels within normal limits.
Given the patient's recent history of herpes zoster, intravenous acyclovir (10 mg/kg every 8 hours) was begun to treat possible varicella zoster virus-related myelitis. The patient had recovered completely by 48 hours, and this treatment was stopped. Laboratory identifi cation of wild poliovirus type 1 was reported on day 7 after hospital admission, 5 days after fecal samples were submitted. The patient was quarantined in the hospital until 2 fecal specimens taken 7 days apart were negative for poliovirus by cell culture and RT-PCR, a total of 34 days (Table). The public health response, directed by the Department of Human Services, included vaccination of potentially susceptible persons who had been exposed to the index case-patient and home quarantine of his household contacts until poliovirus shedding was excluded. No secondary cases were identifi ed.
At the NPRL, the initial fecal specimen was extracted according to recommended procedures (5) and incubated with 4 continuous mammalian cell lines: L20B, RD-A, Hep2 Cincinnati, and human embryonic lung. After 4 days, enterovirus cytopathic effect was observed in all cell lines except RD-A. This fi nding was after passage onto fresh cell lines to reduce toxicity.
Confi rmatory testing for enterovirus isolation and intratypic differentiation for poliovirus was performed Acute-and convalescent-phase serum specimens were collected on days 15 and 47 after symptom onset, respectively, and tested for total immunoglobulin poliovirus neutralizing antibodies according to recommended methods (6). Antibodies to all 3 poliovirus serotypes were detected in both specimens. The potency of antibodies to authenticated Sabin poliovirus type 1 was 212 and 424 IU for the acute-and convalescent-phase samples, respectively. To have determined the titer of neutralizing antibodies at the onset of symptoms, earlier collection of acute-phase serum would have been needed.
Doubt was cast on the diagnosis of poliomyelitis because of the patient's age, vaccination history, and the initial panenterovirus PCR-negative fecal specimen. However, previous vaccination does not exclude poliomyelitis; reduced seroconversion to polio vaccine is well described in polio-endemic regions (7). Furthermore, although this patient had received oral polio vaccine during childhood, he received no booster dose before his recent travel.
Several factors support an argument against the negative predictive value of the initial fecal panenterovirus RT-PCR. Fecal shedding of poliovirus by infected persons can be intermittent; hence, 2 fecal specimens from suspected case-patients are recommended (5). Panenterovirus RT-PCR was subsequently positive for the second fecal specimen, provided 2 days after the fi rst. In retrospect, the virus titer in the fi rst specimen may have been below the limits of detection for RT-PCR; this limitation was overcome by virus multiplication in cell culture. The panenterovirus RT-PCR is a heminested assay adapted from Zoll et al. (8) by addition of an internal second round primer. This assay's performance in an external proficiency testing program conducted by the Royal College of Pathologists of Australasia (9) has met a high standard. Repeat testing of the fi rst fecal specimen by this assay showed 1 of 15 replicates to be positive, consistent with a low poliovirus copy number. There was no enhancement with contrast. Furthermore, childhood vaccination may have attenuated the duration of virus shedding. Because the travel history, clinical illness, and radiographic appearance were highly suggestive of poliomyelitis, the presumptive diagnosis remained poliomyelitis until confi rmation by fecal culture.

Conclusions
Until polio is completely eradicated, polio-free regions remain at risk for importation and subsequent transmission of poliovirus. Poliomyelitis should be considered in patients who have acute fl accid paralysis or a febrile illness without an alternate diagnosis and who have travelled from countries with endemic poliovirus transmission; neither previous vaccination nor a single negative fecal enteroviral PCR excludes poliomyelitis. The high level of vaccination in Australia reduces the risk for local transmission after poliovirus importation. However, Australia has a large migrant population who might not be immune, and Aboriginal and Torres Strait Islanders exhibit reduced seroconversion rates after polio vaccination (10). Risk for local outbreaks can be minimized by widespread vaccination, early recog-nition of an index case, and prompt and appropriate public health measures.